Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 830.55 | 2243.00 | 1962.75 | 1.1428 | 1.2271 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2278.00 | 1962.75 | 1.1606 | 1.2551 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 1250.00 | 830.55 | 879.00 | 1962.75 | 0.4478 | 0.0468 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 1250.00 | 830.55 | 1473.00 | 1962.75 | 0.7505 | 0.5869 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1331.00 | 1962.75 | 0.6781 | 0.4624 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 1250.00 | 830.55 | 906.00 | 1962.75 | 0.4616 | 0.0726 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 2290.00 | 1962.75 | 1.1667 | 1.2647 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2105.00 | 1962.75 | 1.0725 | 1.1160 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 830.55 | 1308.00 | 1962.75 | 0.6664 | 0.4420 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 829.00 | 1962.75 | 0.4224 | -0.0015 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 830.55 | 2160.00 | 1962.75 | 1.1005 | 1.1605 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1994.00 | 1962.75 | 1.0159 | 1.0256 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 830.55 | 1957.00 | 1962.75 | 0.9971 | 0.9953 |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 1250.00 | 830.55 | 1838.00 | 1962.75 | 0.9364 | 0.8969 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1867.00 | 1962.75 | 0.9512 | 0.9210 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1700.00 | 1962.75 | 0.8661 | 0.7813 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 926.00 | 1962.75 | 0.4718 | 0.0916 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1454.00 | 1962.75 | 0.7408 | 0.5704 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 1803.00 | 1962.75 | 0.9186 | 0.8677 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2452.00 | 1962.75 | 1.2493 | 1.3929 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1951.00 | 1962.75 | 0.9940 | 0.9903 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 945.00 | 1962.75 | 0.4815 | 0.1097 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2462.00 | 1962.75 | 1.2544 | 1.4008 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 830.55 | 2036.00 | 1962.75 | 1.0373 | 1.0599 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2048.00 | 1962.75 | 1.0434 | 1.0697 |